Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03811912
Recruitment Status : Completed
First Posted : January 22, 2019
Last Update Posted : November 17, 2020
Sponsor:
Information provided by (Responsible Party):
Concert Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 21, 2019
Actual Study Completion Date : November 21, 2019
Certification/Extension First Submitted : November 16, 2020